ABIOMED CEO Michael Minogue's 2019 pay jumps 87% to $19M
ABIOMED reports 2019 executive compensation
By ExecPay News
Published: June 25, 2019
ABIOMED reported fiscal year 2019 executive compensation information on June 25, 2019.
In 2019, six ABIOMED executives received on average a compensation package of $5.7M, a 86% increase compared to previous year.
Average pay of disclosed executives at ABIOMED
Michael R. Minogue, Chief Executive Officer, received $19M in total, which increased by 87% compared to 2018. 66% of Minogue's compensation, or $13M, was in stock awards. Minogue also received $1.6M in non-equity incentive plan, $4.3M in option awards, $753K in salary, as well as $8.8K in other compensation.
For fiscal year 2019, the median employee pay was $115,794 at ABIOMED. Therefore, the ratio of Michael R. Minogue's pay to the median employee pay was 166 to one.
David M. Weber, Chief Operating Officer, received a compensation package of $4.4M, which increased by 102% compared to previous year. 60% of the compensation package, or $2.6M, was in stock awards.
Todd A. Trapp, Chief Financial Officer, earned $3.2M in 2019.
Michael G. Howley, Vice President and General Manager, Global Sales, received $2.9M in 2019, which increases by 48% compared to 2018.
Andrew J. Greenfield, Vice President and General Manager, Global Marketing, earned $2.9M in 2019.
Ian McLeod, Chief Financial Officer, received $1.5M in 2019, which increases by 56% compared to 2018.
ABIOMED's fiscal year ends on March 31.
Related executives
Michael Minogue
ABIOMED
Chief Executive Officer
Todd Trapp
ABIOMED
Chief Financial Officer
Ian McLeod
ABIOMED
Chief Financial Officer
Andrew Greenfield
ABIOMED
Executive Vice President and Chief Commercial Officer
David Weber
ABIOMED
Chief Operating Officer
Michael Howley
ABIOMED
Vice President and General Manager, Global Sales
You may also like
Source: SEC filing on June 25, 2019.